Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
24 participants
INTERVENTIONAL
2019-02-18
2019-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Health Effects of Oat and Oat Bioactive in Human
NCT04542265
Health Effects of Oat and Oat Polar Lipids in Human
NCT05139355
Health Effects of Oat Bioactives (Betaglucan) in Human
NCT05801653
Effects of Plant-based Polar Lipids on Acute and Second Meal Glucose Tolerance and Appetite Sensations
NCT05844085
Oat and Cholesterol
NCT03911427
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control product
A glucose solution (glucose and water) based on 42 gram carbohydrates.
Control product
Glucose based beverage without added test components is used as control product
Oat Beverage 1
The test product is an oat based beverage with added vegetable oil. The test portion is based on 42 gram available carbohydrates and consumed as a breakfast meal prior to determinations of test variables in the morning.
Oat Beverage 1
Oat based beverage with added different concentration of extracted oat component.
Oat Beverage 2
The test product is an oat based beverage with added vegetable oil. The test portion is based on 42 gram available carbohydrates and consumed as a breakfast meal prior to determinations of test variables in the morning.
Oat Beverage 2
Oat based beverage with added different concentration of extracted oat component.
Oat Beverage 3
The test product is an oat based beverage with added vegetable oil. The test portion is based on 42 gram available carbohydrates and consumed as a breakfast meal prior to determinations of test variables in the morning.
Oat Beverage 3
Oat based beverage with added different concentration of extracted oat component.
Oat Beverage 4
The test product is an oat based beverage. The test portion is based on 42 gram available carbohydrates and consumed as a breakfast meal prior to determinations of test variables in the morning.
Oat Beverage 4
Oat based beverage with added different concentration of extracted oat component.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Oat Beverage 1
Oat based beverage with added different concentration of extracted oat component.
Oat Beverage 2
Oat based beverage with added different concentration of extracted oat component.
Oat Beverage 3
Oat based beverage with added different concentration of extracted oat component.
Oat Beverage 4
Oat based beverage with added different concentration of extracted oat component.
Control product
Glucose based beverage without added test components is used as control product
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI 18,5 - 25
* non smokers
* consuming a non-vegetarian diet that follows the Nordic guidances
Exclusion Criteria
* known cardio-metabolic disease (e.g. diabetes, hypertension, metabolic syndrome), gastro-intestinal disorders such as IBS (irritable bowel syndrome) that can interfere with the study results, food allergies. Further no antibiotics or probiotics should have been consumed within 4 weeks prior to and during the study.
20 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Swedish Foundation for Strategic Research
OTHER
Lund University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Anne Nilsson
Associate professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anne Nilsson
Role: STUDY_CHAIR
Lund University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Food Technology, engineering and Nutrition, LTH, Lund University
Lund, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Protokoll 2018/8
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.